Age-related macular degeneration is linked to cardiovascular disease

1 Chopdar A Chakravarthy U Verma D. Age related macular degeneration. BMJ 2003; 326:485–8. doi:10.1136/bmj.326.7387.485

2 Wong TY. Age-related macular degeneration and cardiovascular disease in the era of anti-vascular endothelial growth factor therapies. Am J Ophthalmol 2009; 148:327–9. doi:10.1016/j.ajo.2009.05.012

3 Wong TY Klein R Sun C Age-related macular degeneration and risk for stroke. Ann Intern Med 2006; 145:98–106.

4 Wong TY Tikellis G Sun C Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Ophthalmology 2007; 114:86–91. doi:10.1016/j.ophtha.2006.06.039

5 Liao D Mo J Duan Y Is age-related macular degeneration associated with stroke among elderly Americans? Open Ophthalmol J 2008; 2:37–42. doi:10.2174/1874364100802010037

6 Rosenfeld PJ Brown DM Heier JS Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355:1419–31. doi:10.1056/NEJMoa054481

7 Wong TY Liew G Mitchell P. Clinical update: new treatments for age-related macular degeneration. Lancet 2007; 370:204–6. doi:10.1016/S0140-6736(07)61104-0

8 Mitchell P Korobelnik JF Lanzetta P Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmol 2009; epub ahead of print.

9 Tan JS Wang JJ Liew G Age-related macular degeneration and mortality from cardiovascular disease or stroke. Br J Ophthalmol 2008; 92:509–12. doi:10.1136/bjo.2007.131706